Page 5 - Medexus Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Medexus pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Medexus Pharma Today - Breaking & Trending Today

Medexus Pharmaceuticals Inc strikes licensing agreement with medac Gesellschaft für klinische Spezialpräparate mbH to commercialize treosulfan in the US

Medexus Pharmaceuticals Inc strikes licensing agreement with medac Gesellschaft für klinische Spezialpräparate mbH to commercialize treosulfan in the US
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United States , Medexus Pharma , Medexus Pharma Inc , Reduced Toxicity Conditioning , Prescription Drug User Free , New Drug Application , Orphan Drug , ஒன்றுபட்டது மாநிலங்களில் , ப்ரிஸ்க்ரிப்ஶந் மருந்து பயனர் இலவசம் , புதியது மருந்து விண்ணப்பம் , ஆர்ஃபந் மருந்து ,

Medexus Announces Upsize to Previously Announced Bought Deal Public Offering

Message :
Required fields
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, CHICAGO and MONTREAL, Feb. 03, 2021 (GLOBE NEWSWIRE) Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSXV:MDP) (Frankfurt: P731) is pleased to announce that, due to strong demand, it has agreed with Raymond James Ltd. and Stifel GMP, as co-lead underwriters and joint bookrunners, on behalf of a syndicate of underwriters (collectively, the “Underwriters”), to increase the size of its previously announced $20 million “bought deal” offering of units. Pursuant to the upsized deal terms, the Underwriters have agreed to purchase, on a “bought deal” basis, 3,984,078 units (the “Units”) of the Company at a price of $7.10 per Unit (the “Issue Price”) for aggregate gross proceeds to the Company of approximately $28.3 million (the “Offering”). ....

United States , South Australia , Tina Byers , Roland Boivin , Crescendo Communications , Medexus Pharmaceuticals , Medexus Pharmaceuticals Inc , Raymond James Ltd , Venture Exchange , Medexus Pharma Inc , Customer Service , Units Of The Company , Raymond James , Common Share , Each Warrant , Closing Date , Common Shares , Issue Price , Over Allotment Option , Medexus Pharma , United States Securities Act , North American , Chief Executive , Chief Financial , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு ஆஸ்திரேலியா ,

Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class Conditioning Agent for Hematopoietic Stem Cell Transplantation, Treosulfan, in the United States

Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class Conditioning Agent for Hematopoietic Stem Cell Transplantation, Treosulfan, in the United States
February 02, 2021 14:21 ET
| Source:
Medexus Pharmaceuticals Inc
Medexus Pharmaceuticals Inc
Orphan Designated Drug with August 2021 PDUFA date
Management to host conference call at 10:00 AM Eastern Time on February 3, 2021 and
Key Opinion Leader webinar to be held at 2:00 PM Eastern Time on February 5, 2021
TORONTO and CHICAGO and MONTREAL and WEDEL, Germany, Feb. 02, 2021 (GLOBE NEWSWIRE) Medexus Pharmaceuticals Inc. (“
Medexus”) (TSXV: MDP) (OTCQX: MEDXF)
(Frankfurt: P731) is pleased to announce that it and its wholly-owned United States-based subsidiary, Medexus Pharma, Inc. (“ ....

United States , Nordrhein Westfalen , H Joachim Deeg , Medexus Pharma , Miklos Kohary , Natalia Zimonyi Kohary , Tina Byers , Mary Horowitz , Roland Boivin , Marrow Transplant Research , Roberta Uihlein Professor Of Hematologic Research , Deputy Cancer Center , International Blood , International Blood Marrow Transplant Research , University Of Bonn School Medicine , Cancer Research , Medexus Pharmaceuticals , Professor Of Clinical Research , University Of Rochester , Seattle Cancer Care Alliance , University Of Washington School Medicine , Marrow Clinical Trials Network , Venture Exchange , Symphony Health , Regulation Services Provider , Medexus Pharma Inc ,

Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class .
Medexus Pharmaceuticals IncFebruary 2, 2021 GMT
Orphan Designated Drug with August 2021 PDUFA date
Management to host conference call at 10:00 AM Eastern Time on February 3, 2021 and
Key Opinion Leader webinar to be held at 2:00 PM Eastern Time on February 5, 2021
TORONTO and CHICAGO and MONTREAL and WEDEL, Germany, Feb. 02, 2021 (GLOBE NEWSWIRE) Medexus Pharmaceuticals Inc. (“Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) is pleased to announce that it and its wholly-owned United States-based subsidiary, Medexus Pharma, Inc. (“Medexus Pharma” and together with Medexus, the “Company”) entered into a Commercialization and Supply Agreement with medac Gesellschaft für klinische Spezialpräparate m.b.H. (“medac”), pursuant to which medac has granted M ....

United States , Nordrhein Westfalen , Dwet Al , Miklos Kohary , Natalia Zimonyi Kohary , Tina Byers , Mary Horowitz , Roland Boivin , Medexus Pharma , H Joachim Deeg , Marrow Transplant Research , Roberta Uihlein Professor Of Hematologic Research , Deputy Cancer Center , International Blood , International Blood Marrow Transplant Research , University Of Bonn School Medicine , Cancer Research , Medexus Pharmaceuticals , Professor Of Clinical Research , University Of Rochester , Seattle Cancer Care Alliance , University Of Washington School Medicine , Marrow Clinical Trials Network , Venture Exchange , Symphony Health , Regulation Services Provider ,

Game changing brain surgery treatment gets Health Canada approval

Game changing brain surgery treatment gets Health Canada approval
thesuburban.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thesuburban.com Daily Mail and Mail on Sunday newspapers.

United States , New Zealand , United Kingdom , South Korea , Medexus Pharma , Susan Marshall , Roberto Diaz , Access Programme , Brain Tumour Foundation Of Canada , Montreal Neurological Institute , World Health Organization , Health Canada , Mcgill University Health Centre , Brain Tumour Foundation , Gleolan Canada , Special Access Programme , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஜீலாந்து , ஒன்றுபட்டது கிஂக்டம் , தெற்கு கொரியா , சூசன் மார்ஷல் , ரொபெர்டோ டியாஸ் , நுழைவு ப்ரோக்ராம் , மூளை கட்டி அடித்தளம் ஆஃப் கனடா , மான்ட்ரியல் நரம்பியல் நிறுவனம் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,